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Study Objective. The objective of this study was to report on the safety and eﬃcacy of cystocele repair with anterior wall mesh
placedviaatransobturatorroute(Perigeesystem,AMS,Minnetonka,MN).Design.Singlecenterretrospectivestudy.Setting.Single
center hospital setting and Urogynecology practice in the United States. Patients. 77 women presenting with symptomatic anterior
wall prolapse. Intervention. Repair of cystocele with an anterior wall Type I soft-polypropylene mesh placed via a transobturator
approach. Concomitant procedures in other compartment were also completed as indicated. Measurements and Main Results.7 7
women underwent the Perigee procedure at our institution over a 2-year period. The mesh was attached to the pelvic sidewalls at
the level of the bladder neck and near the ischial spine apically with needles passed through the groins and obturator space. Mean
follow-up was 18.2 months (range 3–36 months). Objective cure rate was 93%. Subjectively only two patients have had recurrent
symptomsofprolapse,andonly1ofthesehasrequiredrepeatsurgeryforcystocele.Meshexposurevaginallyoccurredin5patients
(6.5%); however all were treated with estrogen and/or local excision of exposed mesh and had no further sequelae. There were no
incidences of chronic pain, infection, or abscess, and no patient required complete mesh removal for infection, pain, or extrusion.
Conclusion. In select patients with anterior wall prolapse, repair with mesh augmentation via the transobturator route is a safe and
eﬀective procedure with up to 3 years of follow-up.
Copyright © 2009 R. D. Moore and J. R. Miklos. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Pelvic organ prolapse (POP) is a signiﬁcant health issue in
females worldwide [1, 2]. There are approximately 250000
procedures annually in the US for POP, with many women
having to undergo repeat surgery for failure of previous
procedures [2]. Traditional anterior repair of cystocele or
anterior wall prolapse utilizing the patient’s own tissue is a
compensatory procedure that has reported high failure rates
and can result in vaginal shortening and/or constriction.
Additionally, plication or colporrhaphy techniques address
only midline defects and attaches poor-quality tissue to poor
quality tissue, under tension, which most likely contributes
to the high failure rate associated with these types of repairs.
Paravaginal repair completed abdominally or laparoscopi-
cally is a more anatomic procedure; however it still relies on
reattaching the patient’s own native tissue, that has already
failed, back out to the arcus tendineus (white line), and has
never been proven to be more eﬀective in long-term cure
rates than vaginal anterior repair [3].
Graft use in prolapse surgery is somewhat controversial,
however it has been proven to be very eﬀective and has
become a standard of care in the treatment of severe
apical prolapse. Abdominal Y-mesh sacralcolpopexy has the
highest cure rates in literature for vault prolapsed, and the
beneﬁt of utilizing mesh in the repair seems to outweigh
the risks [4]. It results in anatomic repair with minimal
tension and does not rely on the patients weakened tissue
to maintain support. With the success of apical graft use,
more recently, graft augmentation of prolapse repair has
been utilized via the vaginal route. Julian ﬁrst reported on
the useof synthetic meshfor cystocelerepair in 1996 [5],and2 Advances in Urology
Figure 1: Inferior or “apical” needle being passed through the
obturator space to attach the more apical arm of the mesh graft to
the pelvic sidewall at the level of the ischial spine.
more recently there have been multiple reports of various
methods to place grafts via a vaginal approach for cystocele
repair [6–19]. Although improved cure rates compared
to traditional repairs have been reported, most of these
techniques require advanced surgical skills, require large
and diﬃcult dissections, and can carry higher morbidity
compared to traditional repairs. Many diﬀerent techniques
have also been reported on various means to attach the graft
in place, as this has been proven to be somewhat diﬃcult
in the anterior compartment. This lack of standardization as
well as the more complex nature of these repairs has resulted
in slow acceptance of these techniques to utilize a graft in
cystocele repair.
The transobturator space has been shown to be a very
safespacefortheplacementoftension-freetapeslingsforthe
treatment of stress urinary incontinence and has simpliﬁed
the technique of this procedure [20–22]. The space was
then utilized to secure the anterior arms of a tension-free
graft for cystocele repair; however no apical attachment of
the graft was described [15]. The purpose of the current
study is to report on the outcomes of a group of patients
that underwent a standardized minimally invasive vaginal
technique utilizing the transobturator space to pass needles
through for assistance in placement and attachment of an
anterior wall mesh for cystocele repair. The Perigee System
(American Medical Systems, Minnetonka, MN, USA) is a
kit that contains 4 side-speciﬁc, patented, helical needles
designed for each anatomic pass through the obturator
space to attach adjustable a graft to the pelvic sidewall
in 4 locations. The kit was designed in attempts to help
make the placement of an anterior wall graft less invasive,
more simpliﬁed, and standardized. The kit includes a soft,
monoﬁlament, macroporous polypropylene mesh that has
4 self-ﬁxating, adjustable arms with special connectors to
attach to the needles that are passed through the obturator
space.
2.MaterialsandMethods
This study is a descriptive retrospective case series of 77 con-
secutivewomenwithsymptomaticStage2orgreateranterior
wall prolapse (cystocele) that underwent anterior repair with
mesh graft augmentation with needles passed through the
transobturator space utilizing the Perigee procedure over
a 2-year period at our center. Comprehensive preoperative
urogynecologic exams were completed including prolapse
quantiﬁcation utilizing the International Continence Soci-
ety Pelvic Organ Prolapse Quantiﬁcation (POP-Q) staging
system. Additional testing included complex urodynamic
testing to evaluate for the presence of concomitant stress uri-
nary incontinence (or detrusor instability) with and without
the patient’s prolapse reduced. If SUI was documented on
urodynamic testing, with or without the prolapse reduced,
the patient was scheduled for a tension-free sling procedure
at the time of surgery. A sling was not placed prophylactically
in any patient if SUI was not seen on testing. All procedures
were performed by the authors.
2.1. Surgical Procedure. After signing informed consent, the
patients were taken to the operating room and prepped and
draped in the dorsal lithotomy position using adjustable
Allen stirrups. Typically, the anterior compartment was
addressed ﬁrst if other repairs or incontinence procedures
werecompleted.Aweightedspeculumand/oraself-retaining
retractor was utilized to obtain exposure. The anterior wall
of the vagina was inﬁltrated subcutaneously with a solution
of 1/4% lidocaine and 1 : 400000 epinephrine to help with
the dissection plane and reduce bleeding. An anterior wall
incision was made vertically in the midline starting at the
level of the bladder neck and extended down the anterior
wall toward the cervix or vaginal cuﬀ,i fh y s t e r e c t o m yw a s
previously completed. If the uterus had no abnormalities,
a hysterectomy was not completed and the uterus was left
insitu. The incision was stopped 2-3cm short of the cervix
orthevaginalcuﬀ.Ifhysterectomywascompletedatthetime
of the surgery, the cuﬀ was closed horizontally and then the
anterior wall incision was made; however we made sure not
to connect the two incisions; that is, a tissue bridge was left
between the two incisions.
The vaginal epithelium was then grasped and then
dissected oﬀ of the bladder and out laterally to the pelvic
sidewalls up to the level of the ischial spines bilaterally.
Apically and in the midline, the bladder was dissected all
the way up and oﬀ the cuﬀ of the vagina or the cervix if
the uterus was in place. This dissection is essentially the
same as we would complete for an anterior repair. We tried
to make our dissection slightly deeper than we would for
standard anterior repair and leave some of the endopelvic
fascia on the vaginal epithelium in order to reduce the risk of
mesh complications. This dissection leaves a thicker vaginal
epithelium over the mesh once closed. After the dissection
was completed, 4 small stab incisions are made in the groins.
Thesuperiorincisionsweremadeinthegenitofemoralcrease
below the adductor longus tendon at the approximate level
of the clitoral hood. The inferior incisions were made 3cm
inferior and 2cm lateral to the superior incisions bilaterally.
The needles are passed through the groin incisions and the
obturator space (Figure 1) and are brought with direct ﬁnger
guidance through the sidewalls at the level of the bladder
neck and approximately 1.5cm distal to the ischial spineAdvances in Urology 3
Figure 2: Final positioning of the mesh providing support under
the bladder.
apically. The mesh arms are then attached to the needles and
they are pulled back out of the groin incisions.
Once all the needles were removed, the tail of the mesh
was cut according to the patients vaginal length and the
apical aspect of the graft was attached to the pericervical ring
or the cuﬀ of the vagina with absorbable sutures. The arms
were then adusted and tightened in a tension-free fashion
which created a hammock-eﬀect under the bladder and
elevated the bladder back into its normal anatomic position.
The ﬁnal positioning placed the mesh under the bladder and
attached laterally to the arcus tendineus from the bladder
neck up to the ischial spine bilaterally (Figure 2). Minimal
to no vaginal epithelium was excised and the incision closed
with a running, locked 2-0 Vicryl suture. Prior to removing
the plastic sheaths from the adjustable arms, the lateral
aspects of the anterior vaginal wall were checked to ensure
that none of the arms were creating any tension vaginally,
and if so, a ﬁnger was used to push up in this area which
would loosen the tension. The outer plastic sheats were then
removed, which ﬁxated the mesh into place. Cystoscopy
was completed at the end of the case and ureteral patency
conﬁrmed with indigo carmine dye given intravenously.
If an incontinence procedure was completed concomi-
tantly, a separate suburethral incision was made, and the
tension-free sling was placed utilizing standard technique.
Remaining prolapse procedures were then completed as
necessary. Postoperatively, vaginal packing and foley catheter
were left in for 24 hours. If stable, patients were discharged
home on postoperative day one and antibiotics were given
for5dayspostoperatively.Vaginalestrogencreamwasstarted
one week postoperatively and used every other day.
Patientswereevaluatedintheoﬃceat4weeks,3months,
6 months, and then every 6 months thereafter. ICS POP-
Q staging was completed as well as subjective assessment
of prolapse (feeling or seeing a bulge), incontinence and
urinary urgency, and frequency symptoms. Objective cure
was deﬁned if the midline anterior vaginal wall (point Ba)
was < or = to −1.0cm inside the hymenal ring.
Table 1: Demographics.
N = 77
Age (years) 70.5
Parity 2.8
Previous hysterectomy 68.8 %
Menopausal 87.2 %
Estrogen use 27.4 %
Previous repair 40.2%
>1 Previous repair 7.8%
Table 2: Concomitant procedures.
Procedure n %
Hysterectomy 2 2.5
Vaginal Vault
-Laparoscopic sacralcolpopexy 15 19.5
-Laparoscopic sacrohysteropexy 6 7.8
-Apogee 8 10.4
Posterior repair
-No graft 17 22.1
-Mesh graft 12 15.6
-Porcine graft 3 3.9
Tension free slings 32 41.2
3. Results
Patient demographics are presented in Table 1. Of the 77
patients, 24 (31.2%) had Stage 2 prolapse, 38 (49.3%)
Stage 3, and 15 (19.5%) had Stage 4 on preoperative pelvic
examination and POP-Q scoring. The mean Ba value (±SD)
was +2.27 ± 2.0cm outside the vaginal opening. Thirty-one
(40.2%) patients had previous anterior vaginal wall repairs
andhadrecurrentcystoceles.Stressurinaryincontinencewas
present in 44% of patients and tension-free tape slings were
placed at the time of their surgeries. Twenty-two patients
(28.5%) presented with SUI and 12 (15.5%) were discovered
to have occult stress leakage with their prolapse reduced
during urodynamic testing. Concomitant procedures at time
of surgery included 32 patients (41.5%) with posterior
repair (12 with mesh grafts, 3 with porcine dermal grafts),
29 patients (37.6%) with vaginal vault suspension (21
laparoscopic sacralcolpopexy, 8 Apogee procedure), and 2
patients with concomitant hysterectomy (1 LAVH, 1 TVH;
see Table 2). Twenty-one patients (27.2%) were sexually
active prior to surgery.
Average blood loss was 77cc (range 10–400cc). There
were 2 intraoperative bleeds that formed hematomas under
the anterior wall after initial closure that required opening
up the anterior wall incision after ﬁnishing other repairs
(patients were still in the operating room). The hematomas
were evacuated and bleeding was controlled with sutures.
One of these patients required a postop blood transfusion of
2 units of PRBCs on postoperative day 1. This was the only
patient in the series that required transfusion. There were no
postoperative bleeds or hematomas and no patient had to be
taken back to the O.R. for bleeding or pain. There was one4 Advances in Urology
Table 3: Preoperative versus postop POP-Q measurements (mean).
Preoperative Postoperative P-value
Mean POP-Q measurements
Point Ba (cm), anterior wall +2.3 ±2.0 −2.5 ±0.9 <0.5
Point C (cm), cervix or vaginal vault −4.3 ± 4.0 −7.6 ±1.3 <0.5
T o t a lV a g i n a lL e n g t h( c m ) 9 .1 ±1.69 .1 ±0.7N S
midline cystotomy, above the trigone, that occurred during
the dissection of the anterior wall. This was closed in a 2-
layer fashion with absorbable sutures and the mesh was still
placed. There were no bladder injuries passing any of the
needles. The average hospital stay was 1.2 days (range 1 to
4 days). Average time to void was 2.4 days (range 1–10 days).
Foley catheters were taken out on postoperative day one and
voiding trial attempted. If patient did not pass the voiding
trial, she was sent home with an indwelling catheter and
voiding trial was reattempted on postop day 3. The patient
that had the complication of cystotomy had her catheter in
for 10 days and had no sequelae from the injury.
Average followup was 18.1 mos (range 3–36mos ).
Objective cure rate was 93.5%, using a deﬁnition of Ba </=
−1.0 as considered cured. Subjectively only two patients
in the series had a symptomatic failure (97.4% subjective
cure rate). One patient had a repeat repair for symptoms of
pressure and the other is considering repair of the failure.
MeanBavaluewas −2.45 ±0.9,pointCwas −7.6 ±1.3,and
TVL was 9.1cm ± 0.7. Mean vaginal length did not change
statistically from preop values (Table 3). Three patients
suﬀered from postoperative levator myalgia that required
short-term treatment with a muscle relaxant. The pain
resolved in all patients in less than 2 weeks and no patient
suﬀered from long-term pain. One patient suﬀered from
groin pain in the region of the adductor longus tendon and
periurethrally on the same side. She presented at one week
postoperatively with this pain. She was treated conservatively
with pain medicine, muscle relaxants, and rest, and the
pain spontaneously was resolved by postop week number
4. She continues to be pain free and suﬀered no long term
weakness or other sequelae. In this predominantly elderly
postmenopausalpatientgroup,only21%weresexuallyactive
preoperatively, and although no signiﬁcant dyspareunia was
reported postoperatively, no speciﬁc conclusions could be
regarding sexual dysfunction.
Fifty-three patients (68%) complained of urge leakage
and urge symptoms preoperatively and 39 of these patients
(73%) had resolution of these symptoms postoperatively
following their surgery. Three patients (3.8%) developed
denovo urge symptoms postoperatively requiring treatment
with anticholinergic agents. Two patients (2.5%) have had
problems with recurrent UTI’s since surgery.
SevenpatientssuﬀeredfromSUIpostop.Three(4%)had
concomitant tension-free slings (2 TVT, 1 TOT) at time of
surgery that failed. One of these patients had repeat TVT
sling and was cured, one patient had periurethral collagen
and was cured, and the 3rd patient opted for no treatment.
Two patients (2.7%) early in the series suﬀered from preop
SUI; however no sling was placed as it was thought that the
Perigee may be able to be used to treat SUI as well. This
was found not be successful as both patients suﬀered from
persistentSUIpostop.OneunderwentTVTslingat2months
postop and was cured, and the other opted for no treatment
asshehadverymildSUI.Thelasttwopatients(2.7%)didnot
haveSUIpreopneithersubjectivelynorobjectivelywiththeir
prolapsereduced;howevertheydevelopeditpostop.Onehad
subsequentTVT slingandwascured,andtheotheropted for
no treatment as she had very mild symptoms.
There were no postoperative infections of the mesh and
no mesh had to be removed secondary to infection or pain.
No patients had to be taken back to the operating room for
revisionofthemeshorreleaseofthelateralmesharmsdueto
pain. Five patients (6.4%) suﬀered from mesh extrusion due
to healing defects (4 discovered <12 weeks postoperatively,
one at 13 months). All of the extrusions were <1cm in
size with minimal erythema or granulation tissue and no
evidence of infection to the graft or tissue surrounding
it. Four of the 5 patients required revision (5.1% overall
revision rate) in the O.R. which was completed under local
anesthesia and involved a very minor procedure of excising
the exposed mesh and closing the mucosal defect. These
patients all healed with no further extrusion or sequelae. The
fourth patient’s epithelium healed over the defect with use of
estrogen cream alone and did not need revision.
4. Discussion
Repair of anterior wall prolapse has been one of the most
challenging aspects of the pelvic reconstructive surgeon for
many years and continues to be the compartment that
plagues the surgeon with recurrences after repair. The search
for a permanent cure of the cystocele has been going on
for more than a century and continues into present day.
Traditional vaginal repair of cystocele utilizing the patient’s
own tissue is a compensatory procedure that does not
restore normal anatomy and has very high failure rates.
The traditional anterior colporrhaphy plicates weakened
tissue together, under tension which most likely leads to
its high failure rates. Richardson identiﬁed that a large
percentage of cystoceles were actually caused by tears of the
pubocervical fascia away from the arcus tendineus pelvi and
this caused rotational descent of the anterior wall leading to
cystocele[23].Paravaginaldefectrepairshavebeendescribed
abdominally, laparoscopically, and vaginally, and although
they are seemingly more anatomic, they have never been
provenmoreeﬀectivethantraditionalcolporrhaphy[3].This
may again be secondary to the fact that we are still suturingAdvances in Urology 5
Table 4: Review of literature of mesh use in cystocele repair.
Author Year Mesh n Followup
(months)
Anatomical
success rate (%)
Vaginal infection
(%)
Vaginal erosion
(%)
Julian [5] 1996 Marlex 12 24 100 0 8.3
Nicita [6] 1998 Marlex 44 3 93.2 0 2.3
Flood et al. [7] 1998 Marlex 142 36 94.4 3.5 2.1
Mage [8] 1999 Mersuture 46 26 100 0 2.2
Migliari et al. [9] 2000 Prolene 12 20 75 0 0
Hardiman et al. [10] 2000 GyneMesh 18 1 100 0 11.1
Adhoute et al. [11] 2004 GyneMesh 52 27 95 0 3.8
Shah et al. [12] 2004 Prolene 29 25 93.3 0 6.7
Dwyer and O’Reilly
[13]
2004 Atrium 47 29 94 0 7
Milani et al. [14] 2004 Prolene 63 17 94 0 13
de Tayrac et al. [15] 2006 GyneMesh 63 37 89.1 0 9.1
de Tayrac et al. [16] 2007 Sofradim Soft
poly-propylene
132 13 92.3%. 0
6.3
∗Hiltunen et al., [17] 2007 Low-weight
polypropylene
104 12
93.3% versus
61.5% ant repair 01 7
∗Sivaslioglu et al. [18] 2008 Polypropylene
(Sofradim)
90 12
91% versus 72%
(ant repair) 06 . 9
∗Nieminen, et al. [19] 2008 Low-weight
polypropylene
105 24 89% versus 59%
(ant repair) 08 . 0
∗ denotes prospective randomized trial.
the patients own weakened tissue back together and are
relying on this tissue to withhold the same forces that caused
it to fail in the ﬁrst place.
General surgeons have been utilizing synthetic mesh in
the repair of hernias for many years and have seen the
beneﬁt of increased cure compared to repair with native
tissue under tension. Graft use in pelvic surgery has been
reported on for many years; however it is only recently
that its use seems to be more widespread. Although its use
vaginally has been somewhat controversial, most seem to
agree that grafts may be necessary to try to achieve more
anatomic repairs with higher cure rates. The management
of using a mesh graft in the anterior compartment is also
supportedbyarecentCochranereviewthatreportedahigher
rate of recurrent prolapse after anterior colporrhaphy than
after mesh repair [24]. Abdominal sacralcolpopexy utilizing
synthetic mesh has become the gold standard to treat severe
vaginal vault prolapse because of its high success rate and
excellent anatomic outcome. The graft is placed over the top
half of the vagina (in the Y-mesh technique) and is brought
up to and attached to the presacral ligament, a very strong
attachment point. Multiple sutures are placed on the vagina,
which distributes the tension and therefore does not rely on
one or two sutures to suspend and hold on to the top of the
vagina.Itshighoverallsuccessratemayalsolieinthefactthat
the mesh goes approximately 1/3 down the anterior wall and
usually at least halfway down the posterior wall, therefore
giving support to the top of the bladder and over the rectum
which may reduce recurrences in these compartments as
well. Some surgeons even question the need for cystocele
repair when sacralcolpopexy is completed [25].
With the success of apical graft use, more recently,
graft augmentation of prolapse repair has been utilized
via the vaginal route. A review of the series that have
utilized synthetic meshes for vaginal cystocele repair can
be seen in Table 4. Cure rates in the range of 75% to
100% have been reported with followup ranging from one
to 37 months. Although improved cure rates compared
to traditional repairs have been reported, most of these
techniques require advanced surgical skills, require large,
and diﬃcult dissections, and can carry higher morbidity
compared to traditional repairs. Additionally, there is no
standardization to these techniques, and their acceptance for
general use has been slow.
de Tayrac et al., in an attempt to simplify the technique
of graft placement and attachment, were one of the ﬁrst6 Advances in Urology
to utilize the transobturator route for partial attachment of
a mesh graft in the anterior compartment; however, they
only utilized the space to attach the graft laterally at the
level of the bladder neck [15]. The more apical portion of
the graft was placed without attachment under the bladder,
and no apical attachment to the sidewalls or sacrospinous
ligament was utilized. Without apical attachment of the
graft to the sidewalls, the mesh can be displaced, bunch up
in the middle, and possibly lead to complications such as
dyspareunia and/or failure over the long term. de Tayrac
surmised that the failure rate they did observe might have
been secondary to this tension-free placement of the mesh.
In 2004, Rane began devising a technique to utilize the
obturator space to attach the graft not only at the bladder
neck but also more apically through the white line near the
ischial spine utilizing needles passed through the obturator
space. He felt that a strong four-point ﬁxation of the mesh
to the lateral pelvic sidewalls will lead to higher long-term
cure rates. The Perigee procedure was developed based on
these ideas and utilizes two diﬀerent shaped helical needles
passed through the obturator space to attach a mesh graft to
the pelvic sidewall at the level of the bladder neck and higher
up in the vagina near the ischial spine. Anatomic studies
completed on cadavers have shown the needle passages to be
asafedistancefromthecriticalvesselsandnervesinthespace
includingtheobturatorandpudendalvesselsandnerves.The
dissection is the same that is utilized for anterior repair and
does not require dissection into the retropubic space nor to
the sacrospinous ligament therefore keeping the dissection
simpliﬁed and minimizing risks of bleeding. The result of
the procedure is an anterior wall mesh that supports the
bladder from the bladder neck up to the ischial spine and
from sidewall to sidewall.
The current study is one of the ﬁrst reports in the
US literature on a series of patients that underwent the
transobturator Perigee procedure for anterior wall prolapse
with followup greater than a year. We found the surgical
procedure a minimally invasive, safe, and time-eﬃcient
method to place an anterior wall mesh for treatment of
cystocele. We have previously attempted other techniques
of graft placement in the anterior compartment and found
them to be very time-consuming and diﬃcult with extensive
dissections and high risk of bleeding and abandoned them
for these reasons. The Perigee procedure has the advantage
of simplicity and standardization as it comes in a kit with a
prefabricated graft and accompanying needles.
Our series showed excellent anatomic results and an
objective cure rate of 93.5% (Ba </= −1.0) with up to 3 years
of followup (mean 18 mos). Subjectively only two patients
have suﬀered symptomatic prolapse (97.4% subjective cure
rate) and no patient has had prolapse of the anterior wall
outside of the introitus. These results are consistent with
other series utilizing synthetic mesh for cystocele repair;
however we believe the Perigee procedure to be less invasive
and a more simpliﬁed technique to place an anterior wall
graft. Thirty-one patients (40.1%) had previous repairs and
would be considered higher risk for failure; however their
cure rate was consistent with patients that had not had
p r i o rr e p a i ra n dt h e r ew a sn od i ﬀerence in complications
seen in these patients either. In our opinion, this is a group
of patients that beneﬁt the greatest from a graft, given a
previous failure using their own tissue, and the results of
these patients in our series are very encouraging.
Concerning the safety of the procedure, bleeding was
minimal in most cases with average blood loss at 77cc.
Two patients did develop intraoperative hematomas under
the anterior wall during completion of other procedures;
however the bleeding was found to be secondary to the
dissection and not the needle passes through the sidewall.
One of these patients had a blood loss of 400cc and
did require blood transfusion postoperatively; however our
threshold for transfusion in her was lower secondary to her
suﬀering from mild anemia preop as well as sarcoidosis with
diminished lung capacity. She recovered well without any
further sequelae. No patient had any postop bleeding nor
required reoperation for bleeding. One patient suﬀered a
midline cystotomy during the procedure; however this was
during the dissection of the anterior wall and was not related
to the mesh or needle passes. We repaired the cystotomy
with a double layered closure, still placed the mesh, and she
recovered without sequelae.
Recently, concerns over complications with vaginal mesh
a n dv a g i n a lm e s hk i t sh a v eb e e nr a i s e d[ 26]. Complications
that may be related to the mesh itself such as mesh extrusion
vaginally, pain (vaginal, groin, buttock, or leg), dyspareunia,
infection, or ﬁstula have been reported in literature [27, 28].
While these complications certainly are concerning and may
occur, the overall rates of these complications seems very low
both in the current study and in previous studies involving
vaginal mesh and/or mesh kits [29–31]. Additionally, com-
plications such as pain (vaginal, leg, buttock, etc.), infection,
and/or dyspareunia are a risk of any vaginal repair whether it
is a traditional repair without mesh or one with a mesh graft.
These risks certainly do need to be balanced with the beneﬁts
of seemingly higher cure rates observed when a mesh graft
is added to the anterior compartment repair. One also has
to consider that diﬀerent kits or techniques utilize diﬀerent
attachment points, diﬀerent size and shape of needles, and
diﬀerent sizes and make-up of mesh, and therefore these all
can contribute to complications.
There has also been concern of groin-pain following
transobturator procedures; however we did not have any
patients that suﬀered from long-term pain in the groin
region. We feel that this is secondary to the needles being
passed from the outside-in and being careful to stay below
the adductor longus tendon with the superior pass as well
as staying as medial as possible to the ishiopubic ramus
duringbothneedlepasses.Onepatientdidsuﬀerfromshort-
term groin pain and periurethral pain unilaterally; however
this resolved spontaneously by 2 weeks postop. We also feel
that it is very important to avoid any tension on the lateral
mesh arms as this can also lead to not only potential groin
pain but also vaginal pain or dyspareunia. We did have two
patients that suﬀered from vaginal pain postoperatively and
were found to have levator myalgia and pelvic ﬂoor spasm
on exam. They were placed on a muscle relaxant, and both
patients pain, resolved by the fourth week postoperatively.
This type of pain may be secondary to the mesh armsAdvances in Urology 7
traversingthelevatormuscles;howeverwehavealsoseenthis
type of pain with traditional uterosacral vault suspension,
which typically also resolves with time and muscle relaxants.
We did not have any patient present with delayed groin
or vaginal pain and saw no evidence of the mesh arms
“tightening” or the mesh shrinking over time, which could
potentially cause pain to develop further out from surgery.
There has also been signiﬁcant concern over the thought
that the use of mesh or mesh kits causes an increased risk
of dyspareunia compared to traditional repair [32]; however
this does not seem to be the case in literature. The overall
risk of pain with intercourse with traditional repairs without
mesh has been reported to be as high as 36% and therefore
not an insigniﬁcant risk [33]. Recent studies have actually
shown that vaginal mesh does not seem to have a negative
impact on sexual function [34, 35], prospective comparative
studies between mesh and traditional repairs in the anterior
compartment have shown no signiﬁcant diﬀerence in rates
of dyspareunia [31], and one has actually shown a lower risk
of dyspareunia in the mesh group [36]. Risk of dyspareunia
or vaginal pain can be kept to a minimal by ensuring that
the mesh lies ﬂat in the space and is placed tension-free; that
is, the mesh arms penetrating the sidewalls should not be
pulled too tight or create a “band” as this can cause pain
withorwithoutintercourse.Additionally,asgrafttechnology
continues to improve, a lighter, less dense type I mesh may
also help reduce these risks even more.
The complication of vaginal mesh extrusion has made
many surgeons very hesitant to utilize synthetic mesh
vaginally. In the current series, our overall rate of mesh
extrusion was 6.4% (5/77), which is consistent with other
reportsinliterature.Allextrusionsbutonewereseenpriorto
12 weeks postoperatively. One patient healed spontaneously
with vaginal estrogen treatment alone, and the other four
required minor revision in the O.R. under local anesthesia
and mild sedation (5.1% overall revision rate). We have
found that when an extrusion occurs, it is typically a very
small defect that can be treated easily with small excision
and closure of the epithelium that does not result in long-
term sequelae. No patient suﬀered from infection of the
mesh or required removal of the entire graft secondary
to infection or pain. We feel the low extrusion rate, and
minimal morbidity is secondary to the mesh being a soft
macroporous monoﬁlament polypropylene (Type I) mesh,
which seems to be the best tolerated graft material available
today for vaginal surgery. We also feel that, by keeping
the vaginal incision as small as possible, making a slightly
deeper dissection, excising minimal vaginal epithelium, and
utilizing pre- and postoperative vaginal estrogen help keep
mesh extrusion rates as low as possible. Vaginal erosion
of synthetic mesh is a common, but seemingly accepted,
complication of abdominal sacralcolpopexy with an overall
rate of 3.4%; however typically these erosions occur at the
apex of the vagina [4]. We have found that these types of
extrusions are much more diﬃcult to manage compared to
the small distal extrusions that may occur with vaginal mesh
placements.
In conclusion, we have found that the vaginal repair
of anterior wall prolapse utilizing an anterior wall mesh
placedwithneedlespassedthroughthetransobturatorspace,
a safe minimally invasive and eﬀective procedure for the
treatment of anterior wall prolapse in this subset of mostly
postmenopausal patients. We feel that the role of mesh in
vaginal repairs is in its infancy, and much study still needs
to be done to determine the ideal material to be utilized
and the optimal way to place and attach the graft vaginally
and the proper patient to utilize it in. A limitation of
any surgical trial that also has to be considered is surgeon
experience,expertise,andskillswiththeparticularprocedure
and anatomy. Complications in the current trial may have
been kept to a minimal secondary to this variable (i.e., a
higher level of expertise) and therefore the translation of
the results to general ob/gyns and/or urologists must be
considered. The current study is limited by its retrospective
nature and medium-term followup and we do recommend
further prospective studies with longer term followup prior
to recommending its general use in clinical practice.
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